References
- Mellinger GD, Baiter MB, Uhlenhuth EH. Insomnia and its treatment: prevalence and correlates. Arch Gen Psychiatry 1985: 42(3): 225–32
- Kales A, Kales JD. Evaluation and treatment of insomnia. New York: Oxford Univ Press, 1984
- Jacques CH, Lynch JC, Samkoff JS. The effects of sleep loss on cognitive performance of resident physicians. J Fam Pract 1990: 30(2): 223–9
- Johnson LC, Spinweber CL. Good and poor sleepers differ in Navy performance. Mil Med 1983: 148(9): 727–31
- Hinges DF, Carskadon MA, Czeisler CA, et al. Attending to inattention. (Letter) Science 1989: 245: 342
- Mitler MM, Carskadon MA, Czeisler CA, et al. Catastrophes, sleep and public policy: consensus report. Sleep 1988: 11(1): 100–9
- Coleman RM, Dement WC. Falling asleep at work: a problem for continuous operations. Sleep Res 1986: 15: 265
- Gillin JC, Byerley WF. Drug therapy: the diagnosis and management of insomnia. N Engl J Med 1990: 322(4): 239–48
- Esther MS, Fredrickson PA, Richardson JW, et al. Association of abnormal alcohol self screening test (AAST) and sleep disorders diagnoses. Sleep Res 1988: 17: 274
- Bunnell DE, Devier W, Horvath SM. Effects of exhaustive exercise on the sleep of men and women. Psychophysiology 1983: 20(1): 50–8
- Bayer AJ, Bayer EM, Pathy MS, et al. A double-blind controlled study of chlormethiazole and triazolam as hypnotics in the elderly. Acta Psychiatr Scand Suppl 1986: 329: 104–11
- Adam K, Oswald I. Can a rapidly-eliminated hypnotic cause daytime anxiety? Pharmacopsychiatry 1989: 22(3): 115–9
- Bixler EO, Kales A, Brubaker BH, et al. Adverse reactions to benzodiazepine hypnotics: spontaneous reporting systems. Pharmacology 1987: 35(5): 286–300
- Oswald I. Triazolam syndrome 10 years on. (Letter) Lancet 1989: 2(8660): 451–2
- Merlotti L, Roehrs T, Koshorek G, et al. The dose effects of Zolpidem on the sleep of healthy normals. J Clin Psychopharmacol 1989;9(1): 9–14
- Scharf MB, Mayleben DW, Kaffeman M, et al. Dose response effects of Zolpidem in normal geriatric subjects. J Clin Psychiatry 1991: 52(2): 77–83
- Vogel GW, Scharf M, Walsh J, et al. Effects of chronically administered Zolpidem on the sleep of healthy insomniacs. (Abstr) Sleep Res 1989: 18: 80
- Vogel GW, Thurmond A, Macintosh M, et al. The effects of Zolpidem on transient insomnia. (Abstr) Sleep Res 1988: 17: 67
- Benavides J, Peny B, Dubois A, et al. In vivo interaction of Zolpidem with central benzodiazepine (BZD) binding sites (as labeled by [3H]Ro 15–1788) in the mouse brain: preferential affinity of Zolpidem for the omega 1 (BZD1) subtype. J Pharmacol Exp Ther 1988: 245(3): 1033–41
- Langer SZ, Arbilla S, Scatton B, et al. Receptors involved in the mechanism of action of Zolpidem. In: Sauvanet JP, Langer SZ, Morselli PL, eds. Imidazopyridines in sleep disorders: a novel experimental and therapeutic approach. New York: Raven Press, 1988: 55–70 (L.E.R.S. monograph series, vol 6)
- Mereu G, Carcangiu G, Concas A, et al. Reduction of reticulata neuronal activity by Zolpidem and alpidem, two imidazopyridines with high affinity for type 1 benzodiazepine receptors. Eur J Pharmacol 1990: 179(3): 339–45
- Sanger DJ, Zivkovic B. Further behavioural evidence for the selective sedative action of Zolpidem. Neuropharmacology 1988: 27(11): 1125–30
- Dennis T, Dubois A, Benavides J, et al. Distribution of central omega 1 (benzodiazepine1) and omega 2 (benzodiazepine2) receptor subtypes in the monkey and human brain: an autoradiographic study with [3H]flunitrazepam and the omega 1 selective ligand [3H]zolpidem. J Pharmacol Exp Ther 1988: 247(1): 309–22
- Roth T, Roehrs T, Koshorek G, et al. Sedative effects of antihistamines. J Allergy Clin Immunol 1987: 80(1): 94–8
- Garrison JC. Histamine, bradykinin, 5-hydroxytryptamine, and their antagonists. In: Gilman AG, Rall TW, Nies AS, et al, eds. Goodman and Gilman's the pharmacological basis of therapeutics. 8th ed. New York: Pergamon Press, 1990: 586